Successful treatment of recurrent thrombotic thrombocytopenic purpura with plasmapheresis and vincristine

Bell WR, Braine HG, Ness PM, Kickler TS (1991) Improved survital in thrombotic thrombocytopenic purpurahemolytic uremic syndrome. N Engl J Med 325: 398–403

Byrnes JJ (1980) Thrombotic thrombocytopenic purpura. Adv Intern Med 26: 131–157

Byrnes JJ, Khurana M (1977) Treatment of thrombotic thrombocytopenic purpura with plasma. N Engl J Med 297: 1386–1389

Douzinas EE, Markakis K, Karabinis A, Mandalaki T, Bilalis D, Fessas P (1992) Early plasmapheresis in patients with thrombotic thrombocytopenic purpura. Crit Care Med 20: 57–61

Finazzi G, Bellavita P, Falanga A, Viero P, Barbui T (1992) Inefficacy of intravenous immunoglobulin in patients with low-risk thrombotic thrombocytopenic purpura/hemolytic-uremic syndrome. Am J Hematol 41: 165–169

Gutterman LA (1992) Treatment of thrombotic thrombocytopenic purpura and hemolytic uremic syndrome: the role of vincristine. In: Kaplan B, Trompeter R, Moake J (eds) Hemolytic uremic syndrome and thrombotic thrombocytopenia purpura. Marcel Dekker, New York, pp 513–530

Gutterman LA, Stevenson TD (1982) Treatment of thrombotic thrombocytopenic purpura with vincristine. JAMA 247: 1433–1436

Kolodziej M (1993) Case report: highdose intravenous immunoglobulin as therapy for thrombotic thrombocytopenic purpura. Am J Med Sci 305: 101–102

Murphy WG, Moore JC, Warkentin TE, Hayward CP, Kelton JG (1992) Thrombotic thrombocytopenic purpura. Blood Coagul Fibrinolysis 3: 655–659

Onundarson PT, Rowe JM, Heal JM, Francis CW (1992) Response to plasma exchange and splenectomy in thrombotic thromnocytopenic purpura. A 10-year experience at a single institution. Arch Intern Med 152: 791–796

Remuzzi G (1987) HUS and TTP: variable expression of a single entity. Kidney Int 32: 292–308

Robertson JH, Crozier EH, Woodend BE (1975) Vincristine therapy of thrombocytopenias. N Engl J Med 292: 108–109

Rock G, Shumak K, Kelton J, Blanchette VS, Buskard N, Nair R, Spasoff R (1992) Thrombotic thrombocytopenic purpura: outcome in 24 patients with renal impairment treated with plasma exchange. Canadian Apheresis Study Group. Transfusion 32: 710–714

Rock GA, Shumak KH, Buskard NA, Blanchette VS, Kelton JG, Nair RC, Spasoff RA (1991) Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. N Engl J Med 325: 393–397

Rose M, Eldor A (1987) High incidence of relapses in thrombotic thrombocytopenic purpura. Am J Med 83: 437–444

Ruggenenti P, Remuzzi G (1990) Thrombotic thrombocytopenic purpura and related disorders. Hematol Oncol Clin North Am 4: 219–239

Ruggenenti P, Galbusera M, Cornejo RP, Bellavita P, Remuzzi G (1993) Thrombotic thrombocytopenic purpura: evidence that infusion rather than removal of plasma induces remission of the disease. Am J Kidney Dis 21: 314–318

Shepard KV, Bukowski RM (1987) The treatment of thrombotic thrombocytopenic purpura with exchange transfusions, plasma infusion, and plasma exchange. Semin Hematol 24: 178–193

Toyoshige M, Zaitsu Y, Okafuji K, Inoue Y, Hiroshige Y, Matsumoto N, Kaku K, Kaneko T (1992) Successful treatment of thrombotic thrombocytopenic purpura with high-dose corticosteroid. Am J Hematol 41: 69

Van Damme-Lombaerts R, Proesmans W, Van Damme B, Eeckels R, Muaka BK, Mercieca V, Vlietinck R, Vermylen J (1988) Heparin plus dipyridamole in childhood hemolyticuremic syndrome: a prospective, randomized study. J Pediatr 113: 913–918

Welborn JL, Emrick P, Acevedo M (1990) Rapid improvement of thrombotic thrombocytopenic purpura with vincristine and plasmapheresis. Am J Hematol 35: 18–21

Welborn JL, O'Donnell R, Hsieh T, Eatherton J, Aspry K (1991) Vincristine for thrombocytopenic purpura. Lancet 337: 377–378